To view the clinical trial data of the following topics click here (pdf format)

Lymphoma

First-line treatment for advanced disease

Stephen Couban, MD, FRCPC, Professor in the Division of Hematology, Dalhousie University; Director of the Capital Health Blood and Marrow Transplant Program

TRIAL SUMMARY: Bendamustine plus rituximab

Multiple myeloma

outcome improvements using combination regimens in older patients

Shamim Wadiwalla, MD, internal medicine resident, Dalhousie University, Saint John, NB and; Tony Reiman, MD, SM, FRCPC, Medical Oncologist, Assistant Dean, Research, Dalhousie Medical Education Program-New Brunswick; Associate Professsor, Medicine, Dalhousie University; Department of Oncology, Saint John Regional Hospital, Saint John, NB

TRIAL SUMMARY: Treatment of older patients

Colon cancer

impact of kras biomarker in therapy selection

Ralph Wong, MD, FRCPC, Medical Oncologist, St-Boniface General Hospital; Assistant Professor, University of Manitoba, Winnipeg, MB

TRIAL SUMMARY: The KRAS biomarker in metastatic CRC

recent advances in adjuvant therapy

Timothy Asmis, MD, FRCPC, Medical Oncologist, Ottawa Hospital Regional Cancer Centre, Assistant Professor, University of Ottawa

TRIAL SUMMARY: Adjuvant treatment of Stage III disease

Pancreatic cancer

Novel screening tools

Sharlene Gill, MD, MPH, FACP, FRCPC, Associate Professor of Medicine, University of British Columbia and Medical Oncologist, BCCA and; Francine Aubin, MD, FRCPC, GI Oncology Fellow, BCCA.

TRIAL SUMMARY: Early detection of pancreatic cancer

Psychosocial care

Evidence for end-of-life planning

Esther Green, RN, MSc(T) Provincial Head, Nursing and Psychosocial Oncology, Cancer Care Ontario; Assistant Clinical Professor, McMaster University, Hamilton, ON; Bejoy Thomas, MPhil, PhD, Assistant Professor, Department of Psychosocial Oncology, Tom Baker Cancer Centre and University of Calgary, Calgary, AB.

TRIAL SUMMARY: Advanced Care Planning

To view the clinical trial data click here (pdf format)